May 21, 2020 / 10:08 PM / 11 days ago

BRIEF-Aquestive Says Expect To Receive Between Up To $100 Million Of Non-Dilutive Capital From Monetization Of Royalty Stream

May 21 (Reuters) - Aquestive Therapeutics Inc:

* AQUESTIVE THERAPEUTICS ADVANCES ROYALTY MONETIZATION PLAN AS SUNOVION PHARMACEUTICALS’ APOMORPHINE SUBLINGUAL FILM THERAPY RECEIVES FDA APPROVAL

* AQUESTIVE THERAPEUTICS - CONTINUE TO EXPECT CO WILL RECEIVE BETWEEN $50 MILLION TO $100 MILLION OF NON-DILUTIVE CAPITAL FROM MONETIZATION OF ROYALTY STREAM

* AQUESTIVE THERAPEUTICS - POTENTIAL MONETIZATION OF ROYALTY STREAM TO EXTEND CAPITAL RUNWAY WELL INTO 2021 AND POSSIBLY BEYOND Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below